Literature DB >> 12068255

Detection and localization of protein-acetaldehyde adducts in rat brain after chronic ethanol treatment.

Sudarshan C Upadhya1, Vijayalakshmi Ravindranath.   

Abstract

BACKGROUND: Ethanol is metabolized to acetaldehyde in the cell, which is potentially deleterious because it can react with cellular proteins and form protein-acetaldehyde adducts, which can interfere with normal cellular function. Because the primary site of ethanol action is the brain, the present study was carried out to determine whether protein-acetaldehyde adducts are formed in rat brain after chronic ethanol administration.
METHODS: Rats were treated with ethanol for 1 year, and the formation of protein-acetaldehyde adducts was examined by immunoblot analysis and localized in brain by immunohistochemical analysis by using affinity purified antibody to acetaldehyde-hemocyanin adduct.
RESULTS: In the brain of rats administered ethanol for up to 1 year, protein-acetaldehyde adducts were detectable by immunoblot analysis. In brain, mitochondria was the primary site of adduct formation, unlike the liver, where the major protein-acetaldehyde adduct has been detected in the cytosol. Immunohistochemical localization of protein-acetaldehyde adducts in chronic ethanol-treated rat brain demonstrated the selective presence of adducts in cortical neurons, granule cell layer of dentate gyrus, neurons in the midbrain, and granular cell layers of cerebellum.
CONCLUSIONS: These results demonstrate the significant formation of protein-acetaldehyde adducts in rat brain after ethanol ingestion. The modification of mitochondrial proteins in brain by protein-acetaldehyde adduct formation is significant because mitochondrial dysfunction has been implicated in neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12068255

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  8 in total

1.  The influence of L-carnitine suplementation on the antioxidative abilities of serum and the central nervous system of ethanol-induced rats.

Authors:  Agnieszka Augustyniak; Elżbieta Skrzydlewska
Journal:  Metab Brain Dis       Date:  2010-11-12       Impact factor: 3.584

Review 2.  Alcohol Withdrawal and Cerebellar Mitochondria.

Authors:  Marianna E Jung
Journal:  Cerebellum       Date:  2015-08       Impact factor: 3.847

3.  Potential Co-Factor Role of Tobacco Specific Nitrosamine Exposures in the Pathogenesis of Fetal Alcohol Spectrum Disorder.

Authors:  Valerie Zabala; Elizabeth Silbermann; Edward Re; Tomas Andreani; Ming Tong; Teresa Ramirez; Fusun Gundogan; Suzanne M de la Monte
Journal:  Gynecol Obstet Res       Date:  2016-03-15

Review 4.  Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Akiko Sakasai-Sakai; Takanobu Takata; Mikihiro Tsutsumi
Journal:  Nutrients       Date:  2017-06-20       Impact factor: 5.717

Review 5.  Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update.

Authors:  Jasmina Dimitrova-Shumkovska; Ljupcho Krstanoski; Leo Veenman
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

6.  Alcohol ADME in primates studied with positron emission tomography.

Authors:  Zizhong Li; Youwen Xu; Don Warner; Nora D Volkow
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

Review 7.  Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury.

Authors:  Wiramon Rungratanawanich; Ying Qu; Xin Wang; Musthafa Mohamed Essa; Byoung-Joon Song
Journal:  Exp Mol Med       Date:  2021-02-10       Impact factor: 8.718

8.  Alcohol-related brain damage in humans.

Authors:  Amaia M Erdozain; Benito Morentin; Lynn Bedford; Emma King; David Tooth; Charlotte Brewer; Declan Wayne; Laura Johnson; Henry K Gerdes; Peter Wigmore; Luis F Callado; Wayne G Carter
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.